Key result
CPET remains indicated to assess exercise symptoms and capacity despite lacking cost-effectiveness data.
Design
Review
Authors
Loading...
May inform assessment of exercise-related symptoms; leaves open cost-effectiveness pending prospective studies.
Cardiopulmonary exercise testing is a valuable tool for assessing exercise limitation and breathlessness, though its cost-effectiveness requires further prospective evaluation.
Mahler et al. (1996) conducted a review in Chronic cardiorespiratory disorders. Cardiopulmonary Exercise Testing (CPEX) was evaluated. Cardiopulmonary exercise testing is indicated to assess exercise-related symptoms and measure exercise capacity, though data on its cost-effectiveness are currently lacking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: